Literature DB >> 19786999

Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer.

Agnes Jager, Jaap Verweij, Stefan Sleijfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19786999     DOI： 10.1038/nrclinonc.2009.142

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

Authors:  Yixin Wang; Jan G M Klijn; Yi Zhang; Anieta M Sieuwerts; Maxime P Look; Fei Yang; Dmitri Talantov; Mieke Timmermans; Marion E Meijer-van Gelder; Jack Yu; Tim Jatkoe; Els M J J Berns; David Atkins; John A Foekens
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

2.  Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.

Authors:  D Crivellari; M Bonetti; M Castiglione-Gertsch; R D Gelber; C M Rudenstam; B Thürlimann; K N Price; A S Coates; C Hürny; J Bernhard; J Lindtner; J Collins; H J Senn; F Cavalli; J Forbes; A Gudgeon; E Simoncini; H Cortes-Funes; A Veronesi; M Fey; A Goldhirsch
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

3.  Use and outcomes of adjuvant chemotherapy in older women with breast cancer.

Authors:  Sharon H Giordano; Zhigang Duan; Yong-Fang Kuo; Gabriel N Hortobagyi; James S Goodwin
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

4.  Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.

Authors:  Elena B Elkin; Arti Hurria; Nandita Mitra; Deborah Schrag; Katherine S Panageas
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

5.  Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.

Authors:  Ann H Partridge; Philip S Wang; Eric P Winer; Jerry Avorn
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

6.  Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735.

Authors:  Stephen Jones; Frankie Ann Holmes; Joyce O'Shaughnessy; Joanne L Blum; Svetislava J Vukelja; Kristi J McIntyre; John E Pippen; James H Bordelon; Robert L Kirby; John Sandbach; William J Hyman; Donald A Richards; Robert G Mennel; Kristi A Boehm; Wally G Meyer; Lina Asmar; Daniel Mackey; Stefan Riedel; Hyman Muss; Michael A Savin
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

7.  Adjuvant chemotherapy in older women with early-stage breast cancer.

Authors:  Hyman B Muss; Donald A Berry; Constance T Cirrincione; Maria Theodoulou; Ann M Mauer; Alice B Kornblith; Ann H Partridge; Lynn G Dressler; Harvey J Cohen; Heather P Becker; Patricia A Kartcheske; Judith D Wheeler; Edith A Perez; Antonio C Wolff; Julie R Gralow; Harold J Burstein; Ahmad A Mahmood; Gustav Magrinat; Gutav Magrinat; Barbara A Parker; Ronald D Hart; Debjani Grenier; Larry Norton; Clifford A Hudis; Eric P Winer
Journal:  N Engl J Med       Date:  2009-05-14       Impact factor: 91.245

8.  Primary breast cancer in elderly women: biological profile and relation with clinical outcome.

Authors:  Maria Grazia Daidone; Danila Coradini; Gabriele Martelli; Silvia Veneroni
Journal:  Crit Rev Oncol Hematol       Date:  2003-03       Impact factor: 6.312

9.  Modeling the effect of age in T1-2 breast cancer using the SEER database.

Authors:  Patricia Tai; Gábor Cserni; Jan Van De Steene; Georges Vlastos; Mia Voordeckers; Melanie Royce; Sang-Joon Lee; Vincent Vinh-Hung; Guy Storme
Journal:  BMC Cancer       Date:  2005-10-08       Impact factor: 4.430

Review 10.  Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

Authors:  M Clarke; A S Coates; S C Darby; C Davies; R D Gelber; J Godwin; A Goldhirsch; R Gray; R Peto; K I Pritchard; W C Wood
Journal:  Lancet       Date:  2008-01-05       Impact factor: 79.321
  10 in total
  2 in total

Review 1.  RGS6 as a Novel Therapeutic Target in CNS Diseases and Cancer.

Authors:  Katelin E Ahlers; Bandana Chakravarti; Rory A Fisher
Journal:  AAPS J       Date:  2016-03-22       Impact factor: 4.009

Review 2.  Management of early breast cancer in older women: from screening to treatment.

Authors:  Fadwa Elomrani; Maryem Zine; Mohamed Afif; Saad L'annaz; Imane Ouziane; Hind Mrabti; Hassan Errihani
Journal:  Breast Cancer (Dove Med Press)       Date:  2015-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.